State University of New York - Downstate Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, State University of New York - Downstate Medical Center sits in the top decile of US sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count).
State University of New York - Downstate Medical Center: 18 sponsored US clinical trials, 1 recruiting.
State University of New York - Downstate Medical Center sponsors 18 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 14 completed. 3 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Patient Compliance, with 1 trials.
Top-decile sponsor footprint
State University of New York - Downstate Medical Center ranks in the top decile of sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
14 of 17 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
18 total, page 1 of 1
Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer
NCT06030622
Combination Facial Aesthetic Treatment in Millennials
NCT04755595
Examining the Effect of Ondansetron on Bowel Prep Success
NCT05439772
Positive Affect Promotion to Empower Optimal Adherence to HIV Therapy
NCT04035759
Light Emitting Diode-Red Light (LED-RL) Phototherapy for Skin Scarring Prevention
NCT03795116
Pilot: Insulin Sensitivity/Management in Hyperglycemic Patients in Perioperative Period ESRD/Non-ESRD
NCT03526536
Propofol and Dexmedetomidine Versus a Propofol Only Regimen for Sedation During Colonoscopy
NCT03139279
Electrophysiologic Changes in Blacks Treated With CBT for Insomnia
NCT02741336
Synergistic Pharmacologic Intervention for Prevention of ROP (SPIPROP Study)
NCT02344225
Barbershop Talk: HIV Prevention for African American Heterosexual Men
NCT01980771
ACEI/ARB Study in Ambulatory and Day of Surgery Admission Patients
NCT03121092
Effects of Adjunctive Lacosamide on Mood States and Quality of Life (QOL) in Patients With Epilepsy
NCT01296880
Antibiotic Prophylaxis for Simple Hand Lacerations
NCT01155154
Pilot Study: Hypovitaminosis D, Hyperparathyroidism and Hypomagnesemia in Patients With Congestive Heart Failure
NCT00887666
Comparison of Sleep Study Results After Partial Intracapsular Tonsillectomy Versus Total Tonsillectomy
NCT00887471
Survey of Adherence to Immunosuppression and Other Medications in Kidney Transplant Patients
NCT00433134
Open-Label Trial of the Use of Minocycline in the Treatment of Asthma
NCT00536042
Evaluation of the Utility of Minocycline as an Anti-Inflammatory Agent in the Treatment of Asthma
NCT00456677
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 5 |
| Phase 4 | 3 |
What is open in the State University of New York - Downstate Medical Center pipeline
1 recruiting of 18 indexed (6% open); 14 completed (78%).
Phase mix: 3 late (III/IV) vs 7 early (I/II) (early-phase heavy).
Top condition: Patient Compliance (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
State University of New York - Downstate Medical Center: open-pipeline peers nationwide
Peers matched on 18 registered trials and 6% open enrollment, not the therapeutic-area sidebar.
State University of New York - Downstate Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 18 trials (± recruiting share)
- ADC Therapeutics S.A. · 18 trials · 11% recruiting
- Akros Pharma · 18 trials · 0% recruiting
- AO Clinical Investigation and Publishing Documentation · 18 trials · 0% recruiting
- AO Innovation Translation Center · 18 trials · 33% recruiting
Sponsors near 6% open enrollment (± trial volume)
- Boston College · 6% recruiting · 18 trials
- CytoDyn · 6% recruiting · 18 trials
- Dendreon · 6% recruiting · 18 trials
- Intercept Pharmaceuticals · 6% recruiting · 18 trials
Related
What to do with this State University of New York - Downstate Medical Center page
18 registered trials is a research-attention snapshot, not an endorsement of State University of New York - Downstate Medical Center or any single study.
- 1 of State University of New York - Downstate Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Patient Compliance is the condition State University of New York - Downstate Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Patient Compliance trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
State University of New York - Downstate Medical Center pipeline card: 18 registered trials from official public datasets.Report a data error.